Insights in Melanoma Research (IMR)
Mission:
To present the latest research findings that influence the prevention, diagnosis and treatment of melanoma.
Aims & Scope: Insights in Melanoma Research (IMR) is an international, peer reviewed, open access multidisciplinary journal focusing on insights of basic, translational, clinical research and epidemiological studies.
The scope of the Journal is broad, embracing the entire range of studies from the cause and progression of melanoma including the process of metastasis and invasion, proliferation, senescence, apoptosis or gene regulation, latest developments in melanoma diagnosis, prognosis, including biomarkers, and treatment including results of clinical trials; molecular and genetic mechanisms involved in melanoma; Epidemiology of melanoma and precursor lesions, Current management and novel agents for malignant melanoma.
New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches; Targeted drugs; research on melanoma stem cells; Identify new targets and treatment modalities for melanomas.
The journal IMR publishes original research and review articles, short communications, i.e. new findings that merit quick dissemination, and letters to the Editors.
Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by IMR, is properly cited.